BioSpace News Archive

Glaukos Corporation announced that the Therapeutic Goods Administration of Australia has granted regulatory approval for the PRESERFLO MicroShunt intended for the reduction of intraocular pressure in eyes of patients with primary open-angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma progression warrants surgery.

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, announced the formation of its Clinical Advisory Committee.

Third Board appointment of 2021 supports long-term vision for the company’s technology platform for 908 Devices.

Humacyte, Inc. today presented initial data from laboratory and preclinical models demonstrating the potential to engineer a biovascular pancreas to deliver islet cells to produce insulin in Type 1 diabetic patients.

ClearPoint Neuro, Inc. today congratulates BlueRock Therapeutics on the dose administration for the first patient in a Phase 1, open-label study.

Life Effects™ website features real-life stories from patients and caregivers about the reality of living with one or more chronic conditions

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. announced that the parties anticipate the closing of their previously announced merger to occur promptly after approval of their pending Nasdaq listing application.

Collaboration with 23andMe enables robust sharing of de-identified genetic data with researchers worldwide through the Fox Insight Data Exploration Network (Fox DEN)

Delcath Systems, Inc., an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effect after the US market opens on June 28, according to a preliminary list of additions posted June 4.

The Arthritis Foundation has released a mobile app to serve as a new tool for people living with pervasive, chronic pain.